Literature DB >> 6365302

Absorption of oral aminoglycosides following bone marrow transplantation.

T M Rohrbaugh, R Anolik, C S August, F T Serota, P A Koch.   

Abstract

Four patients with severe gastrointestinal reactions receiving oral "nonabsorbable" antibiotics for gut sterilization following bone marrow transplantation absorbed clinically significant amounts of aminoglycoside (gentamicin and/or tobramycin). Serum concentrations of 2.2, 2.6, 5.8, and 12.0 micrograms/ml were measured. Two of these patients had acute graft versus host reactions and two had severe mucositis following cytoreduction with intensive chemotherapy and irradiation. Nephrotoxicity occurred in the latter patients. One patient was studied in detail. Her hospital course and investigative results are presented. Four additional patients with mild gastrointestinal reactions following cytoreduction did not absorb gentamicin when their toxicity was maximal. Serum aminoglycoside determinations are necessary in patients receiving oral aminoglycosides for gut sterilization following bone marrow transplantation if moderate to severe gastrointestinal reactions occur.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6365302     DOI: 10.1002/1097-0142(19840401)53:7<1502::aid-cncr2820530713>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Fasting increases tobramycin oral absorption in mice.

Authors:  Luigina De Leo; Nicola Di Toro; Giuliana Decorti; Noelia Malusà; Alessandro Ventura; Tarcisio Not
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

2.  Vitamin B12 absorption after allogeneic bone marrow transplantation.

Authors:  D W Milligan; A Quick; D L Barnard
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

3.  Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype.

Authors:  John Henry McDermott; Joshua Wolf; Keito Hoshitsuki; Rachel Huddart; Kelly E Caudle; Michelle Whirl-Carrillo; Peter S Steyger; Richard J H Smith; Neal Cody; Cristina Rodriguez-Antona; Teri E Klein; William G Newman
Journal:  Clin Pharmacol Ther       Date:  2021-06-20       Impact factor: 6.875

Review 4.  Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview.

Authors:  N M Blijlevens; J P Donnelly; B E De Pauw
Journal:  Bone Marrow Transplant       Date:  2000-06       Impact factor: 5.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.